IPP Bureau
MHRA clears inavolisib, offering new option for returning breast cancer
By IPP Bureau - November 30, 2025
The oral, film-coated tablet is licensed for patients whose cancer has returned during or shortly after hormone therapy
Europe failing to diagnose HIV early, threatening 2030 AIDS target
By IPP Bureau - November 30, 2025
Gan & Lee Pharma launches Phase 3 trial of once-monthly weight-loss jab
By IPP Bureau - November 30, 2025
InnoCare Pharma launches global Phase II trial of TYK2 inhibitor for prurigo nodularis in China
By IPP Bureau - November 30, 2025
Soficitinib is a potent and selective TYK2 inhibitor under development for multiple T-cell mediated autoimmune disorders
a2z wins FDA nod for groundbreaking abdomen-pelvis CT AI Triage system
By IPP Bureau - November 30, 2025
Abdomen-pelvis CT is the nation’s highest-volume CT category
Ascendis Pharma’s FDA review of Achondroplasia drug gets 3-month delay
By IPP Bureau - November 30, 2025
The FDA has classified recent submissions as a major amendment pushing the approval to its NDA for TransCon CNP back three months to February 28, 2026
Biocon Biologics' Drug Substance Facility in Bengaluru cassified as VAI
By IPP Bureau - November 29, 2025
This relates to the manufacture and supply of Human Recombinant Insulin (rh- Insulin) and Biosimilar Pegfilgrastim Drug Substance to the United States
Mangalam Drugs receives Rs. 15 crore repeat export order
By IPP Bureau - November 29, 2025
The receipt of this order further strengthens the company's position in the global pharmaceutical market
.jpg "Cipla opens India's First dedicated lung health diagnostics center in Delhi")
Cipla opens India's First dedicated lung health diagnostics center in Delhi
By IPP Bureau - November 29, 2025
Amrutanjan re-launches its iconic yellow balm
By IPP Bureau - November 29, 2025
Amrutanjan is also rolling out its new campaign, 'Har Dard Mitaye'
Innoxel Lifesciences completes EU GMP inspection by Belgium's FAMHP
By IPP Bureau - November 29, 2025
The audit was completed with zero critical and zero major observations
Lupin Foundation bags CRISIL's Highest VO 1A rating for Excellence in Social Responsibility
By IPP Bureau - November 29, 2025
This distinction is testament to LHWRF's dedication to excellence, transparency, and impact in the realm of social responsibility
Akums Drugs appoints Yuvraj Datta as President – Operational Strategy & Excellence
By IPP Bureau - November 28, 2025
Most recently, Yuvraj was the Director of Operations, Business Development & Process Excellence at Zeon Lifesciences Ltd
Apollo Pharmacy becomes 7,000-store strong
By IPP Bureau - November 28, 2025
The 7,000th store was inaugurated in Ayodhya, Uttar Pradesh
Medanta launches 550-bed super speciality hospital in Noida
By IPP Bureau - November 28, 2025
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
